The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).

Hallowell, Nina; Lawton, Julia; Badger, Shirlene; Richardson, Susan; Hardwick, Richard H; Caldas, Carlos; Fitzgerald, Rebecca

View / Open Files

Accepted version (Microsoft Word 2007, 52Kb)

Authors

Hallowell, Nina

Lawton, Julia

Badger, Shirlene

Richardson, Susan

Hardwick, Richard H

Caldas, Carlos

Fitzgerald, Rebecca

Publication Date

2017-08

Journal Title

Journal of genetic counseling

ISSN

1059-7700

Volume

Issue

Pages

752-762

Language

eng

Type

Article

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Hallowell, N., Lawton, J., Badger, S., Richardson, S., Hardwick, R. H., Caldas, C., & Fitzgerald, R. (2017). The Psychosocial Impact of Undergoing Prophylactic Total Gastrectomy (PTG) to Manage the Risk of Hereditary Diffuse Gastric Cancer (HDGC).. Journal of genetic counseling, 26 (4), 752-762. https://doi.org/10.1007/s10897-016-0045-8

Keywords

Humans, Stomach Neoplasms, Genetic Predisposition to Disease, Gastrectomy, Qualitative Research, Quality of Life, Adult, Middle Aged, Female, Male

Sponsorship

Department of Health (via National Institute for Health Research (NIHR)) (NF-SI-0515-10090)

Cancer Research UK (CB4140)

Cancer Research UK (unknown)

Cancer Research UK (60098573)

Cancer Research UK (unknown)

Department of Health (via National Institute for Health Research (NIHR)) (unknown)

EC FP7 NOE (260791)

Cambridge University Hospitals NHS Foundation Trust (CUH) (RG51913)

Cancer Research UK (A15580)

European Commission FP7 Network of Excellence (NoE) (260791)

Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)

Cancer Research UK (16465)

Academy of Medical Sciences (unknown)

MEDICAL RESEARCH COUNCIL (MR/M008975/1)

Academy of Medical Sciences (ALI 01/08/14)

Pathological Society of Great Britain & Ireland (CDF 2012/01)

European Commission FP7 Collaborative projects (CP) (258967)

Cancer Research UK (C507/A16278)

EC FP7 CP (258967)

Cancer Research UK (20544)

MRC (MR/P012442/1)

European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA) FP7 Innovative Medicines Initiative (IMI) (115749)

EC FP7 CP (242006)

ECH2020 EUROPEAN RESEARCH COUNCIL (ERC) (694620)

Cancer Research UK (A24622)

Identifiers

External DOI: https://doi.org/10.1007/s10897-016-0045-8

This record's URL: https://www.repository.cam.ac.uk/handle/1810/280189

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved